These Healthcare stocks are trading higher:
-Senseonics Holdings Inc (SENS) stock is trading at $3.04, a gain of $0.99, or 41.71%, on high volume. Senseonics Holdings gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $2.38.
-Windtree Therapeutics Inc (WINT) stock is trading at $2.90, a rise of $0.92, or 37.85%, on high volume. Windtree Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.75.
-Cullinan Oncology Inc (CGEM) stock is trading at $35.51, an increase of $5.75, or 19.3%, on high volume. Cullinan Management Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $47.75.
-Second Sight Medical Products Inc (EYES) stock is trading at $6.53, a gain of $0.96, or 17.67%, on average volume. Second Sight gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Sell.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Harpoon Therapeutics Inc (HARP) stock is trading at $15.78, a loss of $5.16, or 24.47%, on high volume. Harpoon Therapeutics Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $31.57.
-Purple Biotech ADR (PPBT) stock is trading at $5.61, a decline of $1.11, or 17.11%, on high volume. Purple Biotech Ltd gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $25.00.
-Salarius Pharmaceuticals Inc (SLRX) stock is trading at $1.21, a drop of $0.19, or 14.07%, on high volume. Salarius Pharmaceuticals Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.40.
-Cellectar Biosciences Inc (CLRB) stock is trading at $1.58, a decline of $0.24, or 12.64%, on high volume. Cellectar Biosc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.98.
